简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:The ultra-wealthy are dropping tens of thousands of dollars on "young blood" transfusions, cryonic preservation, and "apocalypse insurance."
The ultra-wealthy are dropping tens of thousands of dollars on preventative measures and treatments meant to help them live forever — or at least, as long as possible.
“Young blood” transfusions, cryonic preservation, and “apocalypse insurance” are a few of the ways billionaires and Silicon Valley tech moguls are investing in their futures.
Billionaire venture capitalist Peter Thiel is one of the major public supporters of research to extend the human lifespan.
“There are all these people who say that death is natural, it's just part of life, and I think that nothing can be further from the truth,” Thiel said back in 2012.
Visit Business Insider's homepage for more stories.
They say money can't buy happiness, but perhaps it can buy immortality — or at least, a longer lifespan than most people.
That seems to be the thinking, at least, of the ultra-wealthy Americans spending thousands on “young blood” transfusions, preserving their bodies through cryonics, and colonizing space in case Earth becomes uninhabitable.
Read more: A controversial startup that charges $8,000 to fill your veins with young blood and halted operations after an FDA warning now says it's back up and running
Commercial finance experts ABC Finance investigated various ways the wealthy are investing in trying to extend their lifespans as much as possible.
Here are five ways the rich are investing in trying to live forever.
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.